Related Experiment Video
Updated: Feb 25, 2026
06:52
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
54.6K
Muckle-Wells syndrome: clinical perspectives.
1Department of Pediatrics, Nîmes University Hospital, INSERM U1183, Montpellier-Nîmes University, Nîmes, France.
Open Access Rheumatology : Research and Reviews
|July 27, 2017
Summary
Muckle-Wells syndrome (MWS) is a rare autoinflammatory disease caused by NLRP3 gene mutations. IL-1 inhibitors significantly improve patient quality of life by targeting excessive interleukin-1β production.
Area of Science:
- Genetics and immunology
- Autoinflammatory diseases
- Rare genetic disorders
Background:
- Muckle-Wells syndrome (MWS) is a rare autoinflammatory disorder.
- It is caused by mutations in the NLRP3 gene, leading to excessive caspase-1 activation and interleukin-1β (IL-1β) production.
- MWS represents an intermediate phenotype within the cryopyrin-associated periodic syndromes spectrum.
Purpose of the Study:
- To review recent findings in Muckle-Wells syndrome.
- To explore genotype/phenotype correlations in MWS.
- To discuss the clinical perspectives and evolving treatment landscape for MWS.
Main Methods:
- Literature review of recent findings in Muckle-Wells syndrome.
- Analysis of genotype-phenotype correlations.
- Discussion of current and future clinical management strategies.
Main Results:
- MWS is linked to NLRP3 gene mutations, causing overactive IL-1β.
- Clinical manifestations include rash, fever, and joint pain, with potential for hearing loss and kidney issues.
- IL-1 inhibitors have markedly improved patient quality of life.
Conclusions:
- Muckle-Wells syndrome is a treatable autoinflammatory condition.
- Understanding genotype-phenotype correlations aids in predicting disease course.
- Targeted therapies like IL-1 inhibitors offer significant clinical benefits and improved prognosis.
Keywords:
CAPSMuckle–Wells syndromeNLRP3 geneanakinraanti-interleukin 1canakinumabclinical presentationcryopyrin-associated periodic syndromerilonaceptMore Related Videos
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
4.7K
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
778
Related Concept Videos
01:22Mitral Stenosis I: Introduction
930
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
930
01:26Nephrotic Syndrome II : Assessment and Medical Management
267
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
267
01:27Mitral Stenosis IV: Nursing Management
313
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
313
01:20Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
01:24Nephrotic Syndrome I : Introduction
734
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
734
01:28Mitral Regurgitation IV: Nursing Management
414
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
414